Hamdard Institute of Medical Sciences & Research (HIMSR)
Search
 

Research Projects – Biochemistry

Research Projects

  1. 2020- SHORT TERM STUDENTSHIP PROGRAM (STS), promoted by The Indian Council of Medical RESEARCH (ICMR); Project titled “Study analyzing the possible role of glycated DNA in the pathophysiology of Pre-diabetes” has been selected (Reference ID 2020 – 10272). (Name of the student – Abhishek Dikshit, MBBS batch 2019, Name of the guide- Dr. Sana Alam, Assistant Professor, Department of Biochemistry)
  2. 2020- Intramural project titled “Utility of hematological & biochemical parameters as a screening tool for assessing COVID-19 infection and its severity as Co-investigator
  3. 2016- SHORT TERM STUDENTSHIP PROGRAM (STS), promoted by The Indian Council of Medical RESEARCH (ICMR); Project titled “Methylglyoxal modified DNA as a marker in diabetes pathophysiology” promoted by The Indian Council of Medical Research (Reference Id 2016-02022) has been awarded. (Name of the student-Aditya Verma, Name of the guide- Dr. Sana Alam, Assistant Professor, Department of Biochemistry)
  4. 2018- SHORT TERM STUDENTSHIP PROGRAM (STS), promoted by The Indian Council of Medical RESEARCH (ICMR); Project titled “Glycated albumin as a novel marker for detecting pre-diabetes” promoted by The Indian Council of Medical Research (Reference Id 2018-02650) has been awarded. (Name of the student-Fahad Ahmad, Name of the guide- Dr. Sana Alam, Assistant Professor, Department of Biochemistry)
  5. 2018- Intramural project accepted titled “Relationship between insulin resistance and hematological parameters in semi urban pre-diabetic population of South Delhi”: An emerging link as Principal Investigator
  6. Assessment of the role of Unani formulations in the prevention of COVID- 19 infection in high-risk population (Project approved by Ministry of AYUSH and sponsored by M/S Hamdard Laboratories India (Medicine Division). Total budget: 32.55 Lakhs
  7. Project title: Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Centre Phase II/III Adaptive Clinical Trial to Assess the Safety and Immunogenicity of Gam-COVID- Vac Combined Vector Vaccine for SARS-Сov-2 Infection in Indian Healthy Subjects sponsored by Dr. Reddy‟s Laboratories Limited.
  8. A phase 2/3, observer-blind, randomized, controlled study to determine the safety and immunogenicity of COVOVAX [sars-cov-2 recombinant spike protein nanoparticle vaccine (sars-cov-2 rs) with matrix-m1TM adjuvant] in Indian adults sponsored by Serum Institute of India and Indian Council of Medical Research, Govt. of India.